Mycotopia Therapies, Inc. (TPIA)
Mycotopia Therapies, Inc. operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Aventura, FL, US. The stock last traded at $0.02, down 5.00% on the session, giving a market capitalisation of $113,827. On trailing twelve-month figures it carries a trailing P/E of 2.07, a net margin of 0.0%. Its beta of 2.56 implies it has historically moved more than the broad market.
Mycotopia Therapies, Inc. specializes in the application of psychedelic compounds to address a range of mental health conditions. The company offers therapeutic interventions for ailments such as post-traumatic stress disorder (PTSD), severe anxiety, depression, and serotonin syndrome, in addition to providing support for palliative care. Headquartered in Aventura, Florida, Mycotopia Therapies, Inc. operates as a subsidiary of EHAVE, Inc.
Mycotopia Therapies, Inc. is most often compared with the following Healthcare names: